Skip to content
Mycointech
Mycointech · Industrial Symbiotic Biotechnology Est. 2000 · Spain · Worldwide

We grow symbiosis

Industrializing Living Symbiosis.

A B2B biotechnology platform for developing high-value agricultural biological products.

Microbial Biotechnology Platform

  • AMF Arbuscular Mycorrhizal Fungi
  • ECM Ectomycorrhizal Fungi
  • ERM Ericoid Mycorrhizal Fungi
  • PGPB Plant Growth-Promoting Bacteria
  • BF Beneficial Fungi & Yeasts

    Trichoderma · Pochonia · Saccharomyces

Scroll · 01 / 12

The infrastructure behind biological agriculture

Know How

25+

Years of biotechnology expertise

Symbiotic infrastructure

20,000

Dedicated in-vivo production surface

Compliance-grade

EU

Ready microbial regulatory frameworks

Global platform

B2B

Partnerships across four continents

03 — Our platform | Advanced biotechnology

One of Europe's largest platforms for in-vivo mycorrhizae production.

20,000

dedicated to large-scale in-vivo multiplication.

500B+

billion spores per year produced through controlled symbiotic multiplication on real host plants.

Designed for manufacturers, formulators, and R&D teams seeking consistent, traceable, and industrial-scale biological supply.

04 — In-vivo technology

Real symbiosis at industrial scale

Not all mycorrhizae are biologically equivalent.

Mycorrhizal quality is not defined by spore concentration alone. Its real value depends on viability, infective capacity, colonization potential and performance under field conditions.

Mycointech multiplies mycorrhizal fungi through in-vivo technology on real host plants, reproducing their natural symbiotic cycle and preserving the structures that define a functional mycorrhizal material: viable spores, hyphae, vesicles, fungal mycelium and colonized root fragments.

This process enables high spore concentration together with other infective propagules capable of initiating new symbiosis, providing manufacturers, formulators and R&D teams with a solid, technically verifiable biological foundation ready to be integrated into high-value agricultural products.

Mycointech · In-vivo

In-vivo

Conventional in-vitro

In-vitro
Real symbiotic cultivation with living host plants
Artificial substrates without complete symbiosis
Complete infective structures: spores, hyphae, vesicles, colonized roots
Partial or non-infective microbial fractions
Preserved biological diversity and functional integrity
Reduced functionality and limited persistence
Industrially traceable and reproducible at scale
Limited scalability and batch variability
Compatible with advanced multi-strain consortia
Restricted compatibility with companion biology
05 — EU registration · 2026

In-vivo mycorrhizal biostimulants with European conformity

Registered in-vivo mycorrhizae for the development of biological products in the European Union.

Mycointech offers a portfolio of in-vivo mycorrhizal biostimulants registered under Regulation (EU) 2019/1009 · PFC 6(A), developed for manufacturers, formulators and B2B brands seeking to incorporate mycorrhizae into their biological product lines with European regulatory support.

Five solutions ready to be integrated into private-label, formulation or product development strategies: four individual AMF species and one advanced five-species consortium, with validated claims, technical documentation and commercial access across all 27 EU Member States.

Explore EU-Registered Solutions Ready for your brand Regulation (EU) 2019/1009 · PFC 6(A)
4
Registered AMF species
1
Registered advanced 5-species consortium
27
European Union markets
Registered species
  • Rhizophagus irregularis
  • Funneliformis mosseae
  • Septoglomus deserticola
  • Claroideoglomus etunicatum

Advanced ENDOM MIX consortium

The only European 5-species AMF consortium registered under Regulation (EU) 2019/1009, designed to provide functional complementarity, scientific differentiation and European regulatory access for high-value biological products.

Industrial in-vivo mycorrhizae production facility
06 — Industrial platform

Not a supplier.
An infrastructure.

01 Symbiotic biology

Living symbiosis, industrialized.

Real plant-fungi-bacteria interactions reproduced at industrial scale, not simulated in artificial media.

02 Microbial infrastructure

Microbial infrastructure as a service.

End-to-end strain custody, propagation, formulation and traceability built for industrial customers.

03 Formulation architecture

Formulation engineered around your market.

Particle size, solubility, carrier, concentration, format and application, designed for your line.

04 Regulatory readiness

EU-grade documentation by default.

Compliance, technical dossiers and market-entry packages aligned with European biological frameworks.

07 — Biological collection

High-value microorganisms for advanced formulations

Mycointech holds a biological collection of mycorrhizal fungi, plant growth-promoting bacteria, beneficial fungi and yeasts selected for the development of professional microbial solutions.

Our biological collection integrates arbuscular mycorrhizal fungi, ectomycorrhizae, ericoid mycorrhizae, PGPB bacteria and complementary microorganisms, providing manufacturers, formulators and R&D teams with a solid foundation to design microbial consortia, biofertilizers and high-value agricultural products.

Mycointech Biological Collection

AMF
Rhizophagus irregularis · Funneliformis mosseae · Septoglomus deserticola · Claroideoglomus etunicatum
PGPB
Bacillus velezensis · Bacillus amyloliquefaciens · Bacillus subtilis · Pseudomonas fluorescens
Beneficial fungi & yeasts
Trichoderma harzianum · Pochonia chlamydosporia · Saccharomyces cerevisiae
ECM / ERM
Pisolithus tinctorius · Rhizopogon spp. · Phialocephala fortinii · Oidiodendron maius
08 — Formulation architecture

Biological formulation, engineered like infrastructure.

Particle size, solubility, carrier, concentration, format and application, designed for your line.

Explore formulation systems
WP / WG

Powder

SC / SL

Liquid

GR / MG

Granular

Seed treatment

Coatings

Inert · Organic

Carriers

Multi-strain blends

Consortia

09 — Proof

Symbiosis, measured.

Root biology

+38%

Average increase in root colonization vs. untreated controls

Agronomic performance

+22%

Yield uplift across multi-site field trials

Input efficiency

-30%

Reduction in mineral fertilizer requirement

Indicative ranges derived from internal R&D and partner field trials across multiple crops, soils and climates. Full technical dossiers available under NDA.

10 — Partnership models

Four ways to integrate Mycointech into your roadmap.

From raw microbial ingredients to long-horizon strategic co-development. Pick the integration model that matches your manufacturing reality.

01

Microbial active ingredients

Industrial-grade raw biology supplied in bulk for integration into your manufacturing line.

02

Custom formulation development

Tailored consortia engineered around crop, climate, application method and target market.

03

Private-label manufacturing

Finished biological products produced under your brand with full technical documentation.

04

Strategic co-development

Long-horizon R&D programs to design defendable, next-generation microbial technologies.

11 — Regulatory readiness

EU-grade compliance, engineered upstream.

Regulatory engineering is built into every formulation from day one, not retrofitted. Our biological products are designed to meet European biological frameworks and to accelerate your market-entry timelines worldwide.

  • EU biostimulant frameworks

    Aligned with EU biostimulant and biological product regulations.

  • Technical dossier preparation

    Documentation and technical dossiers ready for submission.

  • Strain identification & traceability

    Strain identity and traceability documented batch by batch.

  • Multi-market regulatory support

    Regulatory support across multiple European and export markets.

  • Quality assurance documentation

    Batch-level quality, viability and QA records.

12 — Scientific positioning
Microorganisms are becoming the new language of modern agriculture. Mycointech's role is to industrialize that language, and make it scalable, traceable and defendable.
Mycointech R&D · Industrial Symbiotic Biotechnology
Next step

Let's discuss your biological project

Tell us what you want to develop, which market you are targeting and what type of support you need.

Our team will help you define the most suitable biological solution for your project: in-vivo mycorrhizae, PGPB bacteria, microbial consortia, formulation, technical documentation or custom development.

We work with manufacturers, formulators, private-label brands and R&D teams looking to integrate living microorganisms into professional agricultural products.